Myrodia Therapeutics

Myrodia Therapeutics KK is a drug discovery company spun out from Kansai Medical University, co-founded by Drs. Kobayakawa, Taiho Innovation, and Remiges Ventures. The company’s main focus is on artificial hibernation based on the new concept of sensory drug discovery, which harnesses and enhances the body’s innate protective abilities through sensory stimulation. Myrodia Therapeutics is developing small molecule compounds that induce artificial hibernation as a therapeutic agent for acute diseases, utilizing foundational technology and research from Kansai Medical University.